Paul Thielking
Chief Tech/Sci/R&D Officer bei NUMINUS WELLNESS INC.
Vermögen: - $ am 31.03.2024
Profil
Paul Thielking is currently the Chief Science Officer at Numinus Wellness, Inc. Prior to this, he worked as the Director of Psycho Oncology at Huntsman Cancer Institute, an Associate Professor at the University of Utah, and the Chief Scientific Officer at Novamind, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUMINUS WELLNESS INC
-.--% | 01.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Paul Thielking
| Unternehmen | Position | Beginn |
|---|---|---|
| NUMINUS WELLNESS INC. | Chief Tech/Sci/R&D Officer | 10.06.2022 |
Ehemalige bekannte Positionen von Paul Thielking
| Unternehmen | Position | Ende |
|---|---|---|
| Huntsman Cancer Institute | Corporate Officer/Principal | - |
| University of Utah | Corporate Officer/Principal | - |
| NOVAMIND INC. | Chief Tech/Sci/R&D Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| Numinus Wellness, Inc. | |
Novamind, Inc.
 Novamind, Inc. Medical/Nursing ServicesHealth Services Novamind, Inc. is a mental health company, which engages in enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. It offers outpatient mental health services, and provides clinical trial services through its subsidiary. It operates through the Cedar Psychiatry and Cedar Clinical Research business divisions. The company was founded by Yaron Conforti, Jesse Kaplan, and Sruli Weinreb on April 23, 1997 and is headquartered in Toronto, Canada. | Health Services |
| Huntsman Cancer Institute |
